https://orcid.org/0000-0002-2924-9956
Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Harrison C. Bergeron & Ralph A. Tripp. (2022) Breakthrough therapy designation of nirsevimab for the prevention of lower respiratory tract illness caused by respiratory syncytial virus infections (RSV). Expert Opinion on Investigational Drugs 31:1, pages 23-29.
Read now
Read now
Xavier Carbonell-Estrany, Barry S Rodgers-Gray & Bosco Paes. (2021) Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries. Expert Review of Anti-infective Therapy 19:4, pages 419-441.
Read now
Read now
John Stambas, Chunni Lu & Ralph A Tripp. (2020) Innate and adaptive immune responses in respiratory virus infection: implications for the clinic. Expert Review of Respiratory Medicine 14:11, pages 1141-1147.
Read now
Read now
Articles from other publishers (6)
Harrison C. Bergeron, Lawrence M. Kauvar & Ralph A. Tripp. (2023) Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response. Therapeutic Advances in Infectious Disease 10, pages 204993612311611.
Crossref
Crossref
Jackelyn Murray, Harrison C. Bergeron, Les P. Jones, Zachary Beau Reener, David E. Martin, Fred D. Sancilio & Ralph A. Tripp. (2022) Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Viruses 14:5, pages 912.
Crossref
Crossref
Ralph A. Tripp & John Stambas. (2021) Intervention Strategies for Seasonal and Emerging Respiratory Viruses with Drugs and Vaccines Targeting Viral Surface Glycoproteins. Viruses 13:4, pages 625.
Crossref
Crossref
Harrison C. Bergeron, Jackelyn Murray, Ana M. Nuñez Castrejon, Rebecca M. DuBois & Ralph A. Tripp. (2021) Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies. Viruses 13:2, pages 352.
Crossref
Crossref
Eleni Markoutsa, Andrew R. McGill, Anthony Singer, Heta Jadhav, Subhra Mohapatra & Shyam S. Mohapatra. (2021) A multifunctional nanoparticle as a prophylactic and therapeutic approach targeting respiratory syncytial virus. Nanomedicine: Nanotechnology, Biology and Medicine 32, pages 102325.
Crossref
Crossref
Sandra Axberg Pålsson, Aleksandra Dondalska, Joseph Bergenstråhle, Caroline Rolfes, Albin Björk, Laura Sedano, Ultan F. Power, Marie-Anne Rameix-Welti, Joakim Lundeberg, Marie Wahren-Herlenius, Peter Mastrangelo, Jean-Francois Eleouet, Ronan Le Goffic, Marie Galloux & Anna-Lena Spetz. (2020) Single-Stranded Oligonucleotide-Mediated Inhibition of Respiratory Syncytial Virus Infection. Frontiers in Immunology 11.
Crossref
Crossref